ScoreWhy is Sonoscape Medical Corp. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 14.35% and Operating profit at -17.19% over the last 5 years
2
Flat results in Mar 26
- PRE-TAX PROFIT(Q) At CNY -16.73 MM has Fallen at -356.49%
- NET PROFIT(Q) At CNY -11.66 MM has Fallen at -256.26%
- DEBT-EQUITY RATIO (HY) Highest at -35.07 %
3
With ROE of 5.45%, it has a fair valuation with a 2.55 Price to Book Value
- Over the past year, while the stock has generated a return of -33.64%, its profits have risen by 285% ; the PEG ratio of the company is 0.2
- At the current price, the company has a high dividend yield of 0.9
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -33.64% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sonoscape Medical Corp. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sonoscape Medical Corp.
-42.35%
-1.55
33.71%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.35%
EBIT Growth (5y)
-17.19%
EBIT to Interest (avg)
36.67
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.61
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
39.27%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.79%
ROE (avg)
8.45%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
2.34
EV to EBIT
120.56
EV to EBITDA
47.38
EV to Capital Employed
3.08
EV to Sales
2.74
PEG Ratio
0.15
Dividend Yield
1.02%
ROCE (Latest)
2.56%
ROE (Latest)
5.45%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET SALES(9M)
At CNY 1,902.92 MM has Grown at 20.44%
NET PROFIT(9M)
Higher at CNY 176.85 MM
-8What is not working for the Company
INTEREST(Q)
At CNY 1.24 MM has Grown at 32.55%
DEBT-EQUITY RATIO
(HY)
Highest at -25.78 %
NET PROFIT(Q)
Fallen at -37.19%
Here's what is working for Sonoscape Medical Corp.
Net Sales
At CNY 1,902.92 MM has Grown at 20.44%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Here's what is not working for Sonoscape Medical Corp.
Interest
At CNY 1.24 MM has Grown at 32.55%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Profit
Fallen at -37.19%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Debt-Equity Ratio
Highest at -25.78 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
